[Microwave coagulation therapy for liver recurrence after resection of metastatic colorectal cancer--comparison with re-hepatectomy].
One hundred and fifty-three patients with liver metastases from colorectal cancer underwent hepatectomy from 1979 to 1998. Recurrence in the residual liver occurred in 71 of the 129 patients with curative B resection, and re-hepatectomy has been done in 21 of these 71 patients since 1984. The 5-year survival rate is 37.0%. MCT has been performed in ten of these 71 patients who could not undergo re-hepatectomy and one patient received both therapies. The 3-year survival rate is 66.7%, which is statistically better than that of 35 patients who could not undergo re-hepatectomy before we started MCT (3-year survival rate of 20.0%). Re-hepatectomy is quite effective for recurrent liver remetastasis after hepatectomy, and MCT is probably of similar value.
Hasuike
Y
Y
Dept. of Surgery, Osaka National Hospital.
Takeda
Y
Y
Mishima
H
H
Nishishou
I
I
Kikkawa
N
N
D015179:Colorectal Neoplasms / Q000473:pathology*; D004564:Electrocoagulation; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000601:surgery*; D008872:Microwaves / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D018365:Neoplasm, Residual